
Sign up to save your podcasts
Or


Naseem Amin, CEO of Orphalan, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Orphalan is working to transform rare disease treatment.
By John Simboli5
77 ratings
Naseem Amin, CEO of Orphalan, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Orphalan is working to transform rare disease treatment.

3,072 Listeners

1,982 Listeners

1,095 Listeners

2,370 Listeners

950 Listeners

800 Listeners

124 Listeners

338 Listeners

6,090 Listeners

92 Listeners

10,182 Listeners

571 Listeners

149 Listeners

249 Listeners

188 Listeners